Valeo Financial Advisors, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$2,0000.0%1380.0%0.00%
Q4 2020$2,000
+100.0%
1380.0%0.00%
Q3 2020$1,0000.0%1380.0%0.00%
Q2 2020$1,0000.0%1380.0%0.00%
Q1 2020$1,0000.0%1380.0%0.00%
Q4 2019$1,0000.0%1380.0%0.00%
Q3 2019$1,0000.0%1380.0%0.00%
Q2 2019$1,0000.0%1380.0%0.00%
Q1 2019$1,000
-50.0%
1380.0%0.00%
Q4 2018$2,0000.0%1380.0%0.00%
Q3 2018$2,0001380.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders